Results 161 to 170 of about 11,187 (212)

Seroepidemiology of human parvovirus B19 in Taiwan

Journal of Medical Virology, 1999
In order to determine the prevalence and risk factors of human parvovirus B19 (B19) infection in Taiwan, a seroepidemiological study was carried out in 19 townships. Serum samples were collected from 862 healthy residents, who were selected by stratified random sampling from various study areas.
Kuei-Hsiang Lin, San-Lin You, Chien-Jen Chen   +2 more
exaly   +3 more sources

Human parvovirus B19 infection and antiphospholipid antibodies

Autoimmunity Reviews, 2007
Erythema infectiosum is the main manifestation of human parvovirus B19 infections. Further B19-related diseases commonly associated with the acute infection are flue-like symptoms, transient aplastic crisis, transient arthralgias, leukopenia and ...
Philipp Von Landenberg, Susanne Modrow
exaly   +2 more sources

Human parvovirus B19 in pregnancy

Hospital Medicine, 2000
Parvovirus B19 infection can result in an adverse outcome when acquired during pregnancy. However, in the majority of cases a successful outcome can be anticipated. Public awareness of this condition is essential and obstetricians should be familiar with the options available to them if they are presented with this clinical problem.
J E, Brennand, A D, Cameron
openaire   +2 more sources

Human Parvovirus B19 and Pregnancy

Clinics in Perinatology, 1988
Although B19 infection during pregnancy usually has no adverse effect on the fetus, it can cause fetal death. Recent studies make it possible to estimate risk of infection following different types of exposure and the risk of fetal death after infection.
L J, Anderson, E S, Hurwitz
openaire   +2 more sources

Human parvovirus B19 infection

Current Opinion in Hematology, 1996
Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells. The pathogenesis of disease resulting from infection is a dynamic between the viral suppression of erythropoiesis and the host's ability to mount an effective immune response.
E, Carper, G J, Kurtzman
openaire   +2 more sources

Fetal lnfection with Human Parvovirus B19

Obstetrical & Gynecological Survey, 1988
The case of premature infant with nonimmune hydrops secondary to human parvovirus B19 infection is presented. The infection was not suspected clinically. The fetal autopsy showed intranuclear inclusions in erythroid cells that stained positively with a DNA hybridization probe for B19 parvovirus.
R A, Franciosi, P, Tattersall
openaire   +2 more sources

Human Parvovirus B19

Pediatric Annals, 1990
The two articles on human parvovirus B19 infection in this issue of the Journal 1 , 2 make important contributions to our understanding of the epidemiology and treatment of the disease.
openaire   +2 more sources

Human Parvovirus B19–Associated Myocarditis

New England Journal of Medicine, 2010
To the Editor: Viral and postviral myocarditis are the major causes of acute and chronic dilated cardiomyopathy.1 To gain insight into the pathogenesis of parvovirus B19–associated myocarditis as an endothelial-cell–mediated disease (Figure 1A), we measured viral loads in endomyocardial biopsy specimens obtained from 498 patients (341 men and 157 women;
Claus-Thomas, Bock, Karin, Klingel, Reinhard, Kandolf   +2 more
openaire   +2 more sources

Persistent parvovirus B19 infections in humans

Microbial Pathogenesis, 1989
Persistent B19 infection may be frequent in man and responsible for a variety of chronic diseases. Clinical and in vitro observations suggest that persistence is the result of a balance over time among virus, target cells, and the immune system. Practically, the diagnosis of persistent infection will require molecular rather than immunologic studies ...
N, Frickhofen, N S, Young
openaire   +2 more sources

Human Parvovirus B19 and Blood Products

Vox Sanguinis, 1997
Abstract Background and objectives: Human B19 parvovirus (B19), identified in 1975, was only recognised as the causative agent of fifth disease in 1983. The incidence of viraemia is low, around 1 in 1,000, but is sufficient to ensure that most plasma pools for fractionation contain some virus.
C, Prowse, C A, Ludlam, P L, Yap
openaire   +2 more sources